FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064513 [Registered on: 20/03/2024] Trial Registered Prospectively
Last Modified On: 19/03/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of Pain control method with two techniques, Intravenous patient Control Analgesia with drug Morphine (IVPCA morphine)and epidural infusion with drug Levobupivacaine with fentanyl after a surgery named Robotic assisted minimal invasive esophagectomy for Carcinoma Esophagus 
Scientific Title of Study   Pain management after Robot-Assisted minimally invasive esophagectomy,comparison of analgesic efficacy of IV PCA morphine and epidural Levobupivacaine with fentanyl 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  ClinicalTrials.gov 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vishal Bhatnagar 
Designation  Consultant and Head Surgical I.C.U. 
Affiliation  Rajiv Gandhi Cancer Institute & Research Center,Rohini, New Delhi 
Address  Department of Surgical I.C.U. Rajiv Gandhi Cancer Institute & Research Center New Delhi North West Delhi

North West
DELHI
110085
India 
Phone  9910950363  
Fax    
Email  drvishalbhatnagar@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vishal Bhatnagar 
Designation  Consultant and Head Surgical I.C.U. 
Affiliation  Rajiv Gandhi Cancer Institute & Research Center New Delhi 
Address  Department of Surgical I.C.U. Rajiv Gandhi Cancer Institute & Research Center New Delhi North West Delhi

North West
DELHI
110085
India 
Phone  9910950363  
Fax    
Email  drvishalbhatnagar@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vishal Bhatnagar 
Designation  Consultant and Head Surgical I.C.U. 
Affiliation  Rajiv Gandhi Cancer Institute & Research Center New Delhi 
Address  Department of Surgical I.C.U. Rajiv Gandhi Cancer Institute & Research Center New Delhi North West Delhi

North West
DELHI
110085
India 
Phone  9910950363  
Fax    
Email  drvishalbhatnagar@yahoo.com  
 
Source of Monetary or Material Support  
Rajiv Gandhi Cancer Hospital & Research Center Sector-5, Rohini, New Delhi 110085 
 
Primary Sponsor  
Name  Rajiv Gandhi Cancer Institute & Research Center Delhi 
Address  Rajiv Gandhi Cancer Institute & Research Center Sector -5 Rohini Delhi 110085 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vishal Bhatnagar  Rajiv Gandhi Cancer Hospital & Research Center  Department of Surgical ICU
North West
DELHI 
9910950363

drvishalbhatnagar@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Review Board  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C159||Malignant neoplasm of esophagus, unspecified, (2) ICD-10 Condition: C159||Malignant neoplasm of esophagus, unspecified, (3) ICD-10 Condition: C159||Malignant neoplasm of esophagus, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Epidural Local anaesthetic drug with epidural opoids infusion for post operative pain relief  Continuous epidural infusion of 0.0625% Laevobupivacaine with fentanyl 2 mcg/ml @ 6 ml/hour for post op pain relief in robotic-assisted minimal invasive esophagectomy at 6 hr,12hr,24th hourly till 5th post operative day 
Intervention  intravenous patient control analgesia with morphine  patient not having epidural catheter placed in OT and intravenous patient control analgesia with morphine used. Each dose of 0.5mg/1 ml of dose on remote button push at 6 hr,12hr,24th hourly till 5th post operative day 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patient undergoing Robotic esophagectomy
Patients willing to use IV Patient control Analgesia 
 
ExclusionCriteria 
Details  Patient refusal for epidural catheter placement
ASA physical status 3 or more  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pharmacy-controlled Randomization 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Compare VAS pain score to assess postoperative analgesia between two study group  Every 6 hourly on postoperative day then every 12 hourly for next 4 days till epidural catheter in situ or ivPCA morphine till 4th postop day  
 
Secondary Outcome  
Outcome  TimePoints 
Requirement of rescue analgesia doses and total volume of drug used for epidural infusion and in IVPCA group  Every 6 hourly on postoperative day then every 12 hourly for next 4 days till epidural catheter in situ or ivPCA morphine till 4th postop day  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   28/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is the study to compare the analgesic effectiveness and hemodynamic changes of continuous epidural infusion of 0.0625% Levobupivacaine with fentanyl 2mcg/ml in one group and IVPCA morphine in other group fpr Postoperative analgesia  In Robot-assisted minimally invasive esophagectomy. Rescue analgesia will be provided with intravenous injection 50 mg tramadol. 
Close